Entero Therapeutics | 5.24 +0.58 +12.45% | ||
| ENTO | |||
| 高 5.30 | 开 4.71 | 量 38.50万股 | 总市值 832.33万 |
| 低 4.43 | 换 24.24% | 额 191.19万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Entero Therapeutics(ENTO)
08-27 04:15
$Entero Therapeutics(ENTO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-25-083075 Act: 34 Size: 2 MB 网页链接
Entero Therapeutics(ENTO)
09-10 05:05
$Entero Therapeutics(ENTO)$ 8-K Current report, items 1.02, 5.02, and 9.01 Accession Number: 0001104659-25-088663 Act: 34 Size: 197 KB 网页链接
Entero Therapeutics(ENTO)
09-17 18:05
$Entero Therapeutics(ENTO)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001104659-25-090498 Act: 33 Size: 429 KB 网页链接
Entero Therapeutics(ENTO)
09-11 05:25
$Entero Therapeutics(ENTO)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-25-089120 Act: 33 Size: 558 KB 网页链接
Entero Therapeutics(ENTO)
08-16 05:15
$Entero Therapeutics(ENTO)$ 8-K Current report, items 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001104659-25-079322 Act: 34 Size: 250 KB 网页链接
Entero Therapeutics(ENTO)
07-17 04:55
$Entero Therapeutics(ENTO)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001104659-25-068362 Act: 34 Size: 237 KB 网页链接
Entero Therapeutics(ENTO)
09-16 18:05
$Entero Therapeutics(ENTO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-002964 Act: 33 Size: 2 KB 网页链接
Entero Therapeutics(ENTO)
08-19 07:05
$Entero Therapeutics(ENTO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-25-079923 Size: 3 KB 网页链接
Entero Therapeutics(ENTO)
10-07 04:45
$Entero Therapeutics(ENTO)$ 8-K Current report, items 1.01, 2.01, 3.02, 5.03, 7.01, 8.01, and 9.01 Accession Number: 0001104659-25-097138 Act: 34 Size: 849 KB 网页链接
Entero Therapeutics(ENTO)
08-19 07:05
$Entero Therapeutics(ENTO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-25-079924 Size: 3 KB 网页链接
Entero Therapeutics(ENTO)
08-11 21:05
$Entero Therapeutics(ENTO)$ 8-K Current report, items 1.01, 3.02, 5.02, 8.01, and 9.01 Accession Number: 0001104659-25-075970 Act: 34 Size: 1 MB 网页链接
Entero Therapeutics(ENTO)
08-14 23:05
$Entero Therapeutics(ENTO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001410578-25-001790 Act: 34 Size: 9 MB 网页链接
Entero Therapeutics(ENTO)
09-26 22:05
$Entero Therapeutics(ENTO)$ SEC STAFF ACTION SEC Staff Action: ORDER Accession Number: 9999999997-25-003663 Size: 4 KB 网页链接
Entero Therapeutics(ENTO)
08-18 22:45
$Entero Therapeutics(ENTO)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001104659-25-079619 Act: 33 Size: 11 KB 网页链接
Entero Therapeutics(ENTO)
08-27 04:35
$Entero Therapeutics(ENTO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-25-083105 Act: 33 Size: 725 KB 网页链接
Entero Therapeutics(ENTO)
09-13 04:35
$Entero Therapeutics(ENTO)$ 8-K Current report, items 1.01, 5.02, and 9.01 Accession Number: 0001104659-25-089562 Act: 34 Size: 237 KB 网页链接